The role of AMARC and cytokeratin 5/6 in differentiation between carcinoma in situ and reactive urothelial atypia in comparison with previously studied markers
Conclusion: The two markers used in the current study, AMARC and CK5/6, can be used to differentiate between urothelial CIS and reactive atypia.
Source: Egyptian Journal of Pathology - Category: Pathology Tags: Original Articles Source Type: research
More News: Cancer & Oncology | Carcinoma | Carcinoma in Situ | Egypt Health | Men | Pathology | Study